1. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141:835–8.
2. Lampert R, Hayes D. Chapter 35: ethical issues. In: Ellenbogen KA, Wilkoff BL, Kay GN, Chu-Pak Lau, editors. Clinical cardiac pacing, defibrillation and resynchronization therapy. 4th ed. Philadelphia: Elsevier/Saunders; 2011. p. 1040–9.
3. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295:809–18.
4. Hammill SC, Kremers MS, Stevenson LW, et al. Review of the registry’s fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010;7:1340–5.
5. Sherazi S, McNitt S, Aktas MK, et al. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol. 2013;36:1273–9.